Generation of Embryonic Stem Cells and Mice for Duchenne Research

PLoS Currents

Volumn , Issue SEP, 2013, Pages

  Veltrop, Marcel ^a   van der Kaa, Jos ^a   Claassens, Jill ^a   van Vliet, Laura ^a   Verbeek, Sjef ^a   Aartsma Rus, Annemieke ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DYSTROPHIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG;

ANIMAL CELL; ARTICLE; BLASTOCYST; CELL VIABILITY; CHROMOSOME; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; DUCHENNE MUSCULAR DYSTROPHY GENE; EMBRYONIC STEM CELL; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; GENE; GENE DELETION; GENE EXPRESSION; GENETIC ANALYSIS; KARYOTYPE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 84883797759     PISSN: None     EISSN: 21573999     Source Type: Journal    
DOI: 10.1371/currents.md.cbf1d33001de80923ce674302cad7925     Document Type: Article

References (25)

1. Hoffman, E. P., Brown, R. H., Jr., and Kunkel, L. M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell, 51: 919-928, 1987.
2. Emery, A. E. The muscular dystrophies. Lancet, 359: 687-695, 2002.
3. Marden, F. A., Connolly, A. M., Siegel, M. J., and Rubin, D. A. Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging. Skeletal Radiol, 34: 140-148, 2005.
4. Zhou, L. and Lu, H. Targeting fibrosis in Duchenne muscular dystrophy. J Neuropathol Exp Neurol, 69: 771-776, 2010.
5. Aartsma-Rus, A. Overview on DMD exon skipping. Methods Mol Biol, 867: 97-116, 2012.
6. Bremmer-Bout, M., Aartsma-Rus, A., de Meijer, E. J., Kaman, W. E., Janson, A. A., Vossen, R. H., van Ommen, G. J., den Dunnen, J. T., and van Deutekom, J. C. Targeted exon skipping in transgenic hDMD mice: A model for direct preclinical screening of human-specific antisense oligonucleotides. Mol Ther, 10: 232-240, 2004.
7. t Hoen, P. A., de Meijer, E. J., Boer, J. M., Vossen, R. H., Turk, R., Maatman, R. G., Davies, K. E., van Ommen, G. J., van Deutekom, J. C., and den Dunnen, J. T. Generation and characterization of transgenic mice with the full-length human DMD gene. J Biol Chem, 283: 5899-5907, 2008.
8. Beggs, A. H., Koenig, M., Boyce, F. M., and Kunkel, L. M. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet, 86: 45-48, 1990.
9. Liechti-Gallati, S., Koenig, M., Kunkel, L. M., Frey, D., Boltshauser, E., Schneider, V., Braga, S., and Moser, H. Molecular deletion patterns in Duchenne and Becker type muscular dystrophy Hum Genet, 81: 343-348, 1989.
10. Bulfield, G., Siller, W. G., Wight, P. A., and Moore, K. J. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A, 81: 1189-1192, 1984.
11. Martin, G. R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A, 78: 7634-7638, 1981.
12. Evans, M. J. and Kaufman, M. H. Establishment in culture of pluripotential cells from mouse embryos. Nature, 292: 154-156, 1981.
13. Bryja, V., Bonilla, S., Cajanek, L., Parish, C. L., Schwartz, C. M., Luo, Y., Rao, M. S., and Arenas, E. An efficient method for the derivation of mouse embryonic stem cells. Stem Cells, 24: 844-849, 2006.
14. Ying, Q. L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P., and Smith, A. The ground state of embryonic stem cell self-renewal. Nature, 453: 519-523, 2008.
15. Draper, J. S. and Nagy, A. Improved embryonic stem cell technologies. Handb Exp Pharmacol, 107-128, 2007.
16. Vilain, E. and McCabe, E. R. Mammalian sex determination: from gonads to brain. Mol Genet Metab, 65: 74-84, 1998.
17. Spitali, P., Heemskerk, H., Vossen, R. H., Ferlini, A., den Dunnen, J. T., t Hoen, P. A., and Aartsma-Rus, A. Accurate quantification of dystrophin mRNA and exon skipping levels in duchenne muscular dystrophy. Lab Invest, 90: 1396-1402, 2010.
18. Aartsma-Rus, A., Bremmer-Bout, M., Janson, A. A., den Dunnen, J. T., van Ommen, G. J., and van Deutekom, J. C. Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy. Neuromuscul Disord, 12 Suppl 1: S71-S77, 2002.
19. Malusky, S., Lopes, P., Kaufman, F., and Wheeler, M. In vivo follicular response to gonadotropin stimultation and in vitro embryonic development following IVF in the DMD/MDX mutant mouse. The Society for the Study of reproduction. August 2004.
20. Buehr, M., Meek, S., Blair, K., Yang, J., Ure, J., Silva, J., McLay, R., Hall, J., Ying, Q. L., and Smith, A. Capture of authentic embryonic stem cells from rat blastocysts. Cell, 135: 1287-1298, 2008.
21. Harris, D., Huang, B., and Oback, B. Inhibition of MAP2K and GSK3 Signaling Promotes Bovine Blastocyst Development and Epiblast-Associated Expression of Pluripotency Factors. Biol Reprod, 2013.
22. Kanda, A., Sotomaru, Y., Shiozawa, S., and Hiyama, E. Establishment of ES cells from inbred strain mice by dual inhibition (2i). J Reprod Dev, 58: 77-83, 2012.
23. Munoz, D. S., Rue, P., Garcia-Ojalvo, J., and Martinez, A. A. Correlations between the levels of Oct4 and Nanog as a signature for naive pluripotency in mouse embryonic stem cells. Stem Cells, 30: 2683-2691, 2012.
24. Zhu, Y., Li, D. G., Sun, Z. G., Chen, X. J., and Jiang, M. X. Differences in chimera formation and germline transmission between E14 and C2J embryonic stem cells in mice. Zygote, 1-5, 2012.
25. Echigoya Y, Lee J, Rodrigues M, Nagata T, Nozohourmehrabad A, Panesar D, Miskew B, Aoki Y and Yokota T. Mutation types and aging differently affect revertant fiber expansion in dystrophic mdx and mdx52 mice. PLoS One. 2013; 8:e69194.